Microbiota-based biomarkers and therapeutics for cancer management

The authors’ laboratories are supported by the National Key R&D Program of China (No. 2020YFA0509200/2020YFA0509203), Research Talent Hub (RTH) of ITF scheme (ITS/177/21FP), Hong Kong RGC-Research Impact Fund (R4032-21F), Hong Kong RGC-Theme-based Research Scheme (T21-705/20-N), Hong Kong RGC-Collaborative Research Fund (C4039-19GF, C7065-18GF), Hong Kong RGC-General Research Fund (14110819, 14111621, 14116722) and CUHK Vice-Chancellor’s Discretionary Fund (CUHK PDFS2122-4S03).

Comments (0)

No login
gif